MAIA MAIA BIOTECHNOLOGY INC revenue, earnings and financials
For the quarter ended June 30, 2026, MAIA BIOTECHNOLOGY INC reported revenue of n/a, net income of −$7.94M and diluted EPS of −$0.13; for the fiscal year ended December 2025 revenue was n/a.
MAIA annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$24.3M, net income −$22.4M (margin n/a), EPS −$0.70
- Fiscal year ended Dec 2024: revenue $0, gross profit n/a, operating income −$17.0M, net income −$23.3M (margin n/a), EPS −$1.05
- Fiscal year ended Dec 2023: revenue $0, gross profit n/a, operating income −$20.2M, net income −$19.8M (margin n/a), EPS −$1.49
- Fiscal year ended Dec 2022: revenue $0, gross profit n/a, operating income −$16.2M, net income −$15.8M (margin n/a), EPS −$1.75
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$7.79M, net income −$12.6M (margin n/a), EPS −$2.37
MAIA quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$7.94M, EPS −$0.13
- Quarter ended Mar 31, 2026: revenue n/a, net income −$6.37M, EPS −$0.14
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$3.63M, EPS −$0.09
- Quarter ended Sep 30, 2025: revenue n/a, net income −$8.90M, EPS −$0.27
- Quarter ended Jun 30, 2025: revenue n/a, net income −$5.35M, EPS −$0.18
- Quarter ended Mar 31, 2025: revenue n/a, net income −$4.52M, EPS −$0.16
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$3.57M, EPS −$0.08
- Quarter ended Sep 30, 2024: revenue n/a, net income −$2.74M, EPS −$0.11
- Quarter ended Jun 30, 2024: revenue n/a, net income −$8.88M, EPS −$0.40
- Quarter ended Mar 31, 2024: revenue n/a, net income −$8.07M, EPS −$0.46
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$6.26M, EPS −$0.40
- Quarter ended Sep 30, 2023: revenue n/a, net income −$4.88M, EPS −$0.36
- Quarter ended Jun 30, 2023: revenue n/a, net income −$4.52M, EPS −$0.35
- Quarter ended Mar 31, 2023: revenue n/a, net income −$4.12M, EPS −$0.38
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$4.15M, EPS −$0.37
- Quarter ended Sep 30, 2022: revenue n/a, net income −$4.90M, EPS −$0.48
- Quarter ended Jun 30, 2022: revenue n/a, net income −$3.31M, EPS −$0.40
- Quarter ended Mar 31, 2022: revenue n/a, net income −$3.41M, EPS −$0.50
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$2.42M, EPS n/a
- Quarter ended Sep 30, 2021: revenue n/a, net income −$5.20M, EPS −$1.02
MAIA cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$18.8M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$15.7M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$13.1M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$12.1M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$4.12M, share buybacks n/a
MAIA balance sheet
- Jun 30, 2026: cash $0, total assets $28.2M, total liabilities $7.57M, shareholders' equity $20.7M
- Mar 31, 2026: cash $0, total assets $35.3M, total liabilities $7.56M, shareholders' equity $27.8M
- Dec 31, 2025: cash $0, total assets $9.70M, total liabilities $7.33M, shareholders' equity $2.38M
- Sep 30, 2025: cash $0, total assets $11.8M, total liabilities $11.7M, shareholders' equity $41.7K
- Jun 30, 2025: cash $0, total assets $11.0M, total liabilities $7.17M, shareholders' equity $3.88M
- Mar 31, 2025: cash $0, total assets $11.9M, total liabilities $6.92M, shareholders' equity $4.94M
- Dec 31, 2024: cash $0, total assets $10.2M, total liabilities $6.52M, shareholders' equity $3.63M
- Sep 30, 2024: cash $0, total assets $9.24M, total liabilities $7.62M, shareholders' equity $1.62M
Is MAIA profitable?
No. MAIA BIOTECHNOLOGY INC lost $26.8M over the last four quarters.
What is MAIA's EPS?
Diluted earnings per share over the last four quarters were −$0.63; −$0.13 in the latest quarter.